138 related articles for article (PubMed ID: 8052997)
1. A comparison of ovine and equine antivenoms.
Sjostrom L; al-Abdulla IH; Rawat S; Smith DC; Landon J
Toxicon; 1994 Apr; 32(4):427-33. PubMed ID: 8052997
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effect of Crotalus simus and Crotalus durissus ruruima venoms on the equine antibody response towards Bothrops asper venom: implications for the production of polyspecific snake antivenoms.
Dos-Santos MC; Arroyo C; Solano S; Herrera M; Villalta M; Segura A; Estrada R; Gutiérrez JM; León G
Toxicon; 2011 Feb; 57(2):237-43. PubMed ID: 21130107
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Preclinical Properties of Several Available Antivenoms in the Search for Effective Treatment of
Kurtović T; Lang Balija M; Brvar M; Dobaja Borak M; Mateljak Lukačević S; Halassy B
Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33805701
[TBL] [Abstract][Full Text] [Related]
4. Cross-reactivity and heterologous neutralization of crotaline antivenoms used in Argentina.
de Roodt AR; Dolab JA; Fernández T; Segre L; Hajos SE
Toxicon; 1998 Jul; 36(7):1025-38. PubMed ID: 9690795
[TBL] [Abstract][Full Text] [Related]
5. Analysis of camelid antibodies for antivenom development: Neutralisation of venom-induced pathology.
Cook DA; Owen T; Wagstaff SC; Kinne J; Wernery U; Harrison RA
Toxicon; 2010 Sep; 56(3):373-80. PubMed ID: 20412814
[TBL] [Abstract][Full Text] [Related]
6. Similar effectiveness of Fab and F(ab')2 antivenoms in the neutralization of hemorrhagic activity of Vipera berus snake venom in mice.
Lomonte B; León G; Hanson LA
Toxicon; 1996 Oct; 34(10):1197-202. PubMed ID: 8931261
[TBL] [Abstract][Full Text] [Related]
7. Development of Equine IgG Antivenoms against Major Snake Groups in Mozambique.
Guidolin FR; Caricati CP; Marcelino JR; da Silva WD
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004325. PubMed ID: 26730709
[TBL] [Abstract][Full Text] [Related]
8. An affinity purified ovine antivenom for the treatment of Vipera berus envenoming.
Smith DC; Reddi KR; Laing G; Theakston RG; Landon J
Toxicon; 1992 Aug; 30(8):865-71. PubMed ID: 1523678
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the intrageneric neutralization scope of monospecific, bispecific/monogeneric and polyspecific/monogeneric antisera raised in horses immunized with sub-Saharan African snake venoms.
Sánchez A; Durán G; Segura Á; Herrera M; Vargas M; Villalta M; Arguedas M; Moscoso E; Umaña D; Gómez A; Gutiérrez JM; León G
PLoS Negl Trop Dis; 2024 May; 18(5):e0012187. PubMed ID: 38809847
[TBL] [Abstract][Full Text] [Related]
10. Single-reagent one-step procedures for the purification of ovine IgG, F(ab')2 and Fab antivenoms by caprylic acid.
Al-Abdulla I; Casewell NR; Landon J
J Immunol Methods; 2014 Jan; 402(1-2):15-22. PubMed ID: 24246428
[TBL] [Abstract][Full Text] [Related]
11. Neutralization of Vipera and Macrovipera venoms by two experimental polyvalent antisera: a study of paraspecificity.
Archundia IG; de Roodt AR; Ramos-Cerrillo B; Chippaux JP; Olguín-Pérez L; Alagón A; Stock RP
Toxicon; 2011 Jun; 57(7-8):1049-56. PubMed ID: 21530569
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the purity and efficacy of affinity purified avian antivenoms with commercial equine crotalid antivenoms.
Carroll SB; Thalley BS; Theakston RD; Laing G
Toxicon; 1992 Sep; 30(9):1017-25. PubMed ID: 1440638
[TBL] [Abstract][Full Text] [Related]
13. Antivenom for European Vipera species envenoming.
Lamb T; de Haro L; Lonati D; Brvar M; Eddleston M
Clin Toxicol (Phila); 2017 Jul; 55(6):557-568. PubMed ID: 28349771
[TBL] [Abstract][Full Text] [Related]
14. Neutralization of kinin-releasing enzymes from viperid venoms by antivenom IgG fragments.
al-Joufi A; Bailey GS; Reddi K; Smith DC
Toxicon; 1991; 29(12):1509-11. PubMed ID: 1801327
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of four different immunogens for the production of snake antivenoms.
Li Q; Ownby CL
Toxicon; 1992 Nov; 30(11):1319-30. PubMed ID: 1485332
[TBL] [Abstract][Full Text] [Related]
16. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines.
Seddik SS; Wanas S; Helmy MH; Hashem M
J Nat Toxins; 2002 Dec; 11(4):329-35. PubMed ID: 12503876
[TBL] [Abstract][Full Text] [Related]
17. Venomics of Vipera berus berus to explain differences in pathology elicited by Vipera ammodytes ammodytes envenomation: Therapeutic implications.
Latinović Z; Leonardi A; Šribar J; Sajevic T; Žužek MC; Frangež R; Halassy B; Trampuš-Bakija A; Pungerčar J; Križaj I
J Proteomics; 2016 Sep; 146():34-47. PubMed ID: 27327134
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of two antivenoms against the venom of North American snakes.
Sánchez EE; Galán JA; Perez JC; Rodríguez-Acosta A; Chase PB; Pérez JC
Toxicon; 2003 Mar; 41(3):357-65. PubMed ID: 12565759
[TBL] [Abstract][Full Text] [Related]
19. Experimental evaluation of ovine antisera to Thai cobra (Naja kaouthia) venom and its alpha-neurotoxin.
Sells PG; Jones RG; Laing GD; Smith DC; Theakston RD
Toxicon; 1994 Dec; 32(12):1657-65. PubMed ID: 7725333
[TBL] [Abstract][Full Text] [Related]
20. Development of simple standard assay procedures for the characterization of snake venom.
Theakston RD; Reid HA
Bull World Health Organ; 1983; 61(6):949-56. PubMed ID: 6609011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
